Previous Page  40 / 56 Next Page
Information
Show Menu
Previous Page 40 / 56 Next Page
Page Background

52 

Chapter 2

Cardiovascular Care

DRUG THERAPY

Several drug classes are critical to the

treatment of cardiovascular disorders.

These drug classes include:

Antianginals:

Beta-adrenergic blockers

Calcium channel blockers

Nitrates

Antiarrhythmics:

Sodium channel blockers

Beta-adrenergic blockers

Potassium channel blockers

Calcium channel blockers

Antiplatelet

Aspirin

P2Y12 Receptor Inhibition

Glycioriteub llb/llla Inhibitors

Anticoagulants:

Unfractionated heparin

(parenteral)

Low-molecular-weight heparins

(parenteral)

Direct thrombin inhibitors

(parenteral and oral)

Coumadin derivatives (oral)

Antifactor Xa inhibitors

(parenteral and oral)

Antihypertensives:

Angiotensin-converting enzymes

(ACE)

Angiotensin ll receptor blockers

(ARBs)

Beta-adrenergic blockers

Calcium channel blockers

Diuretics

Selective aldosterone receptor

antagonists

Sympatholytics

Vasodilators

Antilipemics:

Bile-sequestering drugs

Cholesterol absorption inhibitors

Fibric-acid derivatives

HMG-CoA reductase inhibitors

(Statins)

Nicotinic acid (niacin)

PCSK9 inhibitors

Inotropics

Thrombolytics

TREATMENTS AND PROCEDURES

How Thrombolytics Help Restore Circulation

When a thrombus forms in an artery, it obstructs the blood supply, causing

ischemia and necrosis. Thrombolytics can dissolve thrombi in the coronary

and pulmonary arteries, restoring the blood supply to the area beyond the

blockage.

OBSTRUCTED ARTERY

A thrombus blocks blood flow through the artery, causing distal ischemia.

INSIDE THE THROMBUS

The thrombolytic enters the thrombus and binds to the fibrin-plasminogen

complex, converting inactive plasminogen into active plasmin. Active

plasmin digests fibrin, dissolving the thrombus. As the thrombus dissolves,

blood flow resumes.

Blood

supply

Artery

wall

Thrombolytic

Plasminogen

Fibrin strand

Active

plasmin

Break

in fibrin

strand

Thrombus

Ischemic

area

Thrombolytics

Thrombolytics can dissolve a clot

or thrombus that has caused acute

MI, ischemic stroke or peripheral

artery occlusion, or PE. They can

also dissolve thrombi and reestablish

blood flow in arteriovenous cannulas,

grafts, and IV catheters. In an

acute or emergency situation, they

must be administered within 3 to

6 hours after the onset of symptoms.

Thrombolytics include:

Streptokinase (Streptase)

Alteplase (tPA)

Tenecteplase (TNKase)

Reteplase (Retavase)